SLEEP COMPLEX
SLEEP COMPLEX, licence 80122236: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Sleep Complex with Melatonin, Magnesium, Ashwagandha, Probiotics
- Licence holder
- Smoky Mountain Ventures, LLC dba SMNUTRITION
- NPN or DIN-HM
- 80122236
- Status
- Active licence
- Licence date
- 2 December 2022
- Revision date
- 8 September 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Matricaria chamomilla | 10.0 mg | Not calculated |
| N-Acétyl-5-méthoxytryptamine Source : Mélatonine | 1.5 mg | Not calculated |
| Melissa officinalis Source : Melissa officinalis - Herb top | 10.0 mg | Not calculated |
| Rhodiola rosea Source : Rhodiola rosea - Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 40 mg | 10.0 mg | Not calculated |
| Withania somnifera Source : Withania somnifera - racine | 10.0 mg | Not calculated |
Non-medicinal ingredients
farine de riz, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 ans | minimum: 1.0 Capsule ; maximum: 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm) and increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule (e.g. shift work and jet lag). Helps to speed up/reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people who fall asleep slowly/with delayed sleep phase disorder. Source of (an) antioxidant(s)/Provides (an) antioxidant(s). Source of probiotics.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80122236
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.